Gao Y, Arkwright PD, Carter R, Cazaly A, Harrison RJ, Mant A, Cant AJ, Gadola S, Elliott TJ, Khakoo SI, Williams AP. Bone marrow transplantation for MHC class I deficiency corrects T-cell immunity but dissociates natural killer cell repertoire formation from function. J Allergy Clin Immunol. 2016;138(6):1733-1736.e2. https://doi.org/10.1016/j.jaci.2016.06.029.
Article CAS PubMed PubMed Central Google Scholar
Li W, Kim MG, Gourley TS, McCarthy BP, Sant’Angelo DB, Chang CH. An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population. Immunity. 2005;23(4):375–86. https://doi.org/10.1016/j.immuni.2005.09.002.
Article CAS PubMed Google Scholar
Zhou TA, Hsu HP, Tu YH, Cheng HK, Lin CY, Chen NJ, Tsai JW, Robey EA, Huang HC, Hsu CL, Dzhagalov IL. Thymic macrophages consist of two populations with distinct localization and origin. Elife. 2022;30(11):e75148. https://doi.org/10.7554/eLife.75148.
Klein L, Kyewski B, Allen PM, Hogquist KA. Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see). Nat Rev Immunol. 2014;14(6):377–91. https://doi.org/10.1038/nri3667.
Article CAS PubMed PubMed Central Google Scholar
Haspot F, Li HW, Lucas CL, Fehr T, Beyaz S, Sykes M. Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells. Am J Transplant. 2014;14(1):49–58. https://doi.org/10.1111/ajt.12525.
Article CAS PubMed Google Scholar
Lerner EC, Woroniecka KI, D’Anniballe VM, Wilkinson DS, Mohan AA, Lorrey SJ, Waibl-Polania J, Wachsmuth LP, Miggelbrink AM, Jackson JD, Cui X, Raj JA, Tomaszewski WH, Cook SL, Sampson JH, Patel AP, Khasraw M, Gunn MD, Fecci PE. CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis. Nat Cancer. 2023;4(9):1258–72. https://doi.org/10.1038/s43018-023-00600-4.
Article CAS PubMed PubMed Central Google Scholar
Xing S, Ferrari de Andrade L. NKG2D and MICA/B shedding: a ‘tag game’ between NK cells and malignant cells. Clin Transl Immunol. 2020;9(12):e1230. https://doi.org/10.1002/cti2.1230.
Anderson CK, Reilly EC, Lee AY, Brossay L. Qa-1-restricted CD8+ T cells can compensate for the absence of conventional T cells during viral infection. Cell Rep. 2019;27(2):537-548.e5. https://doi.org/10.1016/j.celrep.2019.03.059.
Article CAS PubMed PubMed Central Google Scholar
Fisher JG, Doyle ADP, Graham LV, Khakoo SI, Blunt MD. Disruption of the NKG2A:HLA-E immune checkpoint axis to enhance NK cell activation against cancer. Vaccines (Basel). 2022;10(12):1993. https://doi.org/10.3390/vaccines10121993.
Article CAS PubMed Google Scholar
Furukawa H, Yabe T, Akaza T, Tadokoro K, Tohma S, Inoue T, Tokunaga K, Yamamoto K, Geraghty DE, Juji T. Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient. Tissue Antigens. 1999;53(3):292–5. https://doi.org/10.1034/j.1399-0039.1999.530310.x.
Article CAS PubMed Google Scholar
Bessoles S, Grandclément C, Alari-Pahissa E, Gehrig J, Jeevan-Raj B, Held W. Adaptations of natural killer cells to self-MHC class I. Front Immunol. 2014;22(5):349. https://doi.org/10.3389/fimmu.2014.00349.
He Y, Tian Z. NK cell education via nonclassical MHC and non-MHC ligands. Cell Mol Immunol. 2017;14(4):321–30. https://doi.org/10.1038/cmi.2016.26.
Article CAS PubMed Google Scholar
Sim MJ, Malaker SA, Khan A, Stowell JM, Shabanowitz J, Peterson ME, Rajagopalan S, Hunt DF, Altmann DM, Long EO, Boyton RJ. Canonical and cross-reactive binding of NK cell inhibitory receptors to HLA-C allotypes is dictated by peptides bound to HLA-C. Front Immunol. 2017;14(8):193. https://doi.org/10.3389/fimmu.2017.00193.
Bern MD, Parikh BA, Yang L, Beckman DL, Poursine-Laurent J, Yokoyama WM. Inducible down-regulation of MHC class I results in natural killer cell tolerance. J Exp Med. 2019;216(1):99–116. https://doi.org/10.1084/jem.20181076.
Article CAS PubMed PubMed Central Google Scholar
Mutascio S, Mota T, Franchitti L, Sharma AA, Willemse A, Bergstresser SN, Wang H, Statzu M, Tharp GK, Weiler J, Sékaly RP, Bosinger SE, Paiardini M, Silvestri G, Jones RB, Kulpa DA. CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness. Immunity. 2023;56(5):1132-1147.e6. https://doi.org/10.1016/j.immuni.2023.03.010.
Article CAS PubMed PubMed Central Google Scholar
Klein M, Schmalzing M, Almanzar G, Benoit S, Hamm H, Tony HP, Goebeler M, Prelog M. Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc). Autoimmunity. 2016;49(8):532–46. https://doi.org/10.1080/08916934.2016.1217997.
留言 (0)